Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference8 articles.
1. E7090, a Novel Selective Inhibitor of Fibroblast Growth Factor Receptors, Displays Potent Antitumor Activity and Prolongs Survival in Preclinical Models;Watanabe Miyano;Mol. Cancer Ther.,2016
2. First-in-human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors;Koyama;Cancer Sci.,2020
3. A validated UPLC-MS/MS assay of E7090, a novel selective inhibitor of fibroblast growth factor receptors, in human plasma and urine;Asakawa;J. Pharm. Biomed. Anal.,2022
4. At-Column-Dilution, Application Notes from Waters (At-Column-Dilution, Application Note (71500078010EN), Revision A. 2003. 〈https://www.waters.com/webassets/cms/library/docs/71500078010rA_AppNotes.pdf〉. (Accessed: 9 March 2022).
5. A method for the direct injection and analysis of small volume human blood spots and plasma extracts containing high concentrations of organic solvents using revered-phase 2D UPLC/MS;Rainville;Analyst,2015